EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and activity evaluation of alpinetin derivatives as potential anti-liver cancer drugs

Yanhui Yi, Yupei Sun, Xiangyang Zhang, Jianzeng Xin, Feng Zhao, Wei Zhu, Sheng Liu

Bioorganic & Medicinal Chemistry Letters · 2026

DOI: 10.1016/j.bmcl.2025.130482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry Letters, 2026. Verfasst von Yanhui Yi und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Yantai University, Yantai 264005, PR China. Hauptthemen laut MEDLINE: Flavanones, Drug Design, Antineoplastic Agents, Liver Neoplasms. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province, Yantai University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver cancer represents a major global health challenge, significantly impacting populations both in China and worldwide. Alpinetin (ALP), extracted from the ginger plant cardamom, has been shown to possess significant anti-liver cancer activity. However, its solubility and mechanism of action remain unclear, hindering its further development and application. Heat shock protein 70 (HSP70) has been proven to be a potential target for the treatment of liver cancer. Based on rational drug design principles, ALP was conjugated with specific pharmacophores through oxime linkages to yield novel compounds, aiming to reduce toxicity and enhanced activity. Thus, representative compounds 1a and 1b were obtained. Then, the preliminary mechanism of action was further investigated. Western blot analysis results indicate that compounds 1a and 1b could inhibit the expression of HSP70 protein in HepG2 liver cancer cells. Cell apoptosis data indicate that the synthesized compounds exert anticancer activity by inducing apoptosis. Therefore, this study suggests that ALP and its derivatives may become promising drugs for exerting anti liver cancer effects by regulating the expression of HSP70 protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavanonesDrug DesignAntineoplastic AgentsLiver NeoplasmsHumansHSP70 Heat-Shock ProteinsHep G2 CellsStructure-Activity RelationshipApoptosisDrug Screening Assays, AntitumorMolecular StructureCell ProliferationDose-Response Relationship, Drug

Stichwörter der Autor:innen

AlpinetinHCC inhibitorHSP70Liver cancer

Substanzen

FlavanonesalpinetinHSP70 Heat-Shock ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmacy, Yantai University, Yantai 264005, PR China.
  • Yantai Key Laboratory of Characteristic Agricultural Bioresource Conservation & Germplasm Innovative Utilization, School of Life Sciences, Yantai University, Yantai 264005, PR China.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: ytuzhaofeng@163.com.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: zhuwei853@163.com.
  • School of Pharmacy, Yantai University, Yantai 264005, PR China. Electronic address: liusheng87@126.com.

Förderung

  • Natural Science Foundation of Shandong Province
  • Yantai University

Zitieren

APA

Yi, Y., Sun, Y., Zhang, X., Xin, J., Zhao, F., Zhu, W., & Liu, S. (2026). Design, synthesis, and activity evaluation of alpinetin derivatives as potential anti-liver cancer drugs. Bioorganic & Medicinal Chemistry Letters. https://doi.org/10.1016/j.bmcl.2025.130482

Vancouver

Yi Y, Sun Y, Zhang X, Xin J, Zhao F, Zhu W, et al. Design, synthesis, and activity evaluation of alpinetin derivatives as potential anti-liver cancer drugs. Bioorganic & Medicinal Chemistry Letters. 2026. doi:10.1016/j.bmcl.2025.130482

BibTeX
@article{Yi2026,
  author = {Yi, Yanhui and Sun, Yupei and Zhang, Xiangyang and Xin, Jianzeng and Zhao, Feng and Zhu, Wei and Liu, Sheng},
  title = {Design, synthesis, and activity evaluation of alpinetin derivatives as potential anti-liver cancer drugs},
  journal = {Bioorganic & Medicinal Chemistry Letters},
  year = {2026},
  doi = {10.1016/j.bmcl.2025.130482}
}
Kostenlos starten →